What pharmacologic therapies have been shown to be most effective for somatic symptom disorder?

What pharmacologic therapies have been shown to be most effective for somatic symptom disorder?

• A. SSRIs and tricyclic antidepressants
• B. Benzodiazepines
• C. Antipsychotics
• D. Mood stabilizers

Answer: (D)

Somatic symptom disorder responds best to ongoing therapeutic engagement and psychotherapy, with medications playing only an adjunct role. The body of evidence does not show a medication class that reliably improves somatic symptoms themselves. When pharmacotherapy is used, it’s typically to treat coexisting mood or anxiety symptoms rather than the somatic symptoms per se. Benzodiazepines are not a good long-term solution because they don’t address the underlying distress and carry dependence risks. Antipsychotics and mood stabilizers likewise lack demonstrated benefit for the somatic symptoms of SSD. If a patient also has depression or anxiety, antidepressants—especially selective serotonin reuptake inhibitors (and sometimes tricyclic antidepressants for comorbid pain or anxiety)—are used to help with those coexisting conditions, which can in turn reduce overall distress and improve functioning. But even then, the meds do not cure SSD itself; the main treatment remains psychotherapy (often CBT) and a consistent, supportive primary-care approach. So, there isn’t a pharmacologic therapy proven to be especially effective for SSD alone; medications are chosen to address any accompanying mood or anxiety disorders rather than the somatic symptoms directly.

Somatic symptom disorder responds best to ongoing therapeutic engagement and psychotherapy, with medications playing only an adjunct role. The body of evidence does not show a medication class that reliably improves somatic symptoms themselves. When pharmacotherapy is used, it’s typically to treat coexisting mood or anxiety symptoms rather than the somatic symptoms per se.

Benzodiazepines are not a good long-term solution because they don’t address the underlying distress and carry dependence risks. Antipsychotics and mood stabilizers likewise lack demonstrated benefit for the somatic symptoms of SSD. If a patient also has depression or anxiety, antidepressants—especially selective serotonin reuptake inhibitors (and sometimes tricyclic antidepressants for comorbid pain or anxiety)—are used to help with those coexisting conditions, which can in turn reduce overall distress and improve functioning. But even then, the meds do not cure SSD itself; the main treatment remains psychotherapy (often CBT) and a consistent, supportive primary-care approach.

So, there isn’t a pharmacologic therapy proven to be especially effective for SSD alone; medications are chosen to address any accompanying mood or anxiety disorders rather than the somatic symptoms directly.